Operational Matters and Part II : The Product Restrictions of Qualifying CIS as prescribed in Appendix C : Standards of Qualifying CIS of the Memorandum of Understanding on Streamlined Authorisation Framework
รายงานการประชุมคณะกรรมการตรวจสอบ ครั้งที่ 4/2548 Ref.: SET-2017-026 December 22, 2017 Subject: Signing on the Memorandum of Understanding to Invest in Medical Service Business for Healthcare and
Understanding to Invest in Medical Service Business for Healthcare and Esthetics under Trademark “Wuttisak” dated December 22, 2017 Since Filter Vision Public Company Limited (“the Company” or “FVC”) declared to
written form to the SEC Office before the expiration of the submission period by demonstrating reasons for request and specifying exact time when the report would be able to be submitted. In case the SEC
before the expiration of the submission period by demonstrating reasons for request and specifying exact time when the report would be able to be submitted. In case the SEC Office determines that such
Memorandum of Understanding to Invest in Medical Service Business for Healthcare and Esthetics under Trademark “Wuttisak” dated December 22, 2017 3. Letter of FVC Ref. No. SET-2017-002: Signing on the
. SET-2017-026: Signing on the Memorandum of Understanding to Invest in Medical Service Business for Healthcare and Esthetics under Trademark “Wuttisak” dated December 22, 2017 3. Letter of FVC Ref. No
businesses in: • understanding the SDGs and how they can contribute to achieving them • understanding what IMM is and how they can integrate IMM frameworks and tools into their business practices and decision
Regulator, and is an accurate translation of that text (where applicable). In this regard, as evidence that each and every page of the documents is of the exact documents to which I/we have certified, I/we
-II-SEC Circular of the Memorandum of Understanding between the Securities and Futures Commission of Hong Kong and the Securities and Exchange Commission of Thailand Concerning Mutual Recognition of